Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Pollen Interference in Hazardous Substance Fluorescence
2026-08-25
The reference study develops a spectral preprocessing and random-forest workflow that reduces pollen interference in excitation–emission matrix fluorescence classification of hazardous bioaerosol components. Its strongest practical contribution is showing that feature transformation, particularly fast Fourier transform processing, can improve discrimination of bacterial and toxin-related signatures without treating pollen as an irrelevant nuisance variable.
-
Necrostatin-1: RIP1 Signaling Beyond Cell Death
2026-08-25
Necrostatin-1 is a selective RIP1 kinase inhibitor for resolving whether cellular injury involves kinase-dependent necroptosis or redox-driven metabolic collapse. This article translates recent osteosarcoma vitamin C findings into a rigorous, mechanism-first assay strategy.
-
HEY2 Biology Meets T7 RNA Polymerase
2026-08-24
The HEY2–HDAC1 regulatory module links cardiac energy failure to transcriptional control. This thought-leadership article explains how T7 RNA Polymerase can help translational researchers convert such mechanistic insights into controlled RNA-based experiments while clarifying the boundaries between platform utility and therapeutic evidence.
-
NVP-BGJ398 Phosphate: FGFR Research Guide
2026-08-24
NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor for studying altered FGFR signaling in cancer and skeletal disease models. Supplier-reported biochemical IC50 values are 0.9 nM for FGFR1, 1.4 nM for FGFR2, and 1 nM for FGFR3, while peer-reviewed mouse data support pharmacological inhibition of FGFR3 signaling in SLC26A2-related chondrodysplasia.
-
C8-HSL: From Quorum Sensing to Cancer Biology
2026-08-23
N-octanoyl-L-Homoserine lactone is evolving from a quorum-sensing reagent into a translational probe for connecting bacterial communication with host-cell signaling. This thought-leadership guide examines the PI3K/AKT/ERK evidence, proposes validation workflows, and outlines responsible paths toward infection biology and cancer–microbiota research.
-
Temafloxacin Activity Against Gram-Positive Bacteria
2026-08-22
The reference study combined new broth-microdilution data with a literature review to define temafloxacin’s enhanced in-vitro activity against clinically important Gram-positive cocci. Its findings support strong activity against Staphylococcus aureus and Streptococcus pneumoniae while also showing how pH, serum, magnesium, urine, and inoculum conditions can affect interpretation.
-
GSK 2837808A: LDHA Inhibition Workflow
2026-08-22
GSK 2837808A is a potent lactate dehydrogenase A inhibitor for dissecting lactate production, glucose consumption, and tumor–immune signaling. This workflow translates its biochemical selectivity into practical cell-based assays for cancer metabolism research while addressing exposure, solubility, and pathway-specific interpretation.
-
MRT68921: Turning Autophagy Off to See It Clearly
2026-08-21
Autophagy research is moving from descriptive imaging toward causal pathway analysis. This thought-leadership article explains how MRT68921, a dual ULK1/2 inhibitor, can help translational researchers connect ULK signaling with lipid metabolism, ATG13 phosphorylation, and LC3 flux while maintaining appropriate preclinical boundaries.
-
Astrocytic GAT-3 Controls Dentate Gyrus Memory
2026-08-20
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than simply a GABA clearance system. Combining electrophysiology, optogenetics, calcium signaling analysis, immunohistochemistry, and contextual fear assays, the authors connect GAT-3-dependent astrocytic Ca2+ signaling with GluN2B-NMDAR-mediated excitation and memory formation.
-
Gut-Brain Cholinergic Signaling in Epilepsy
2026-08-20
Jia et al. identify a microbiota–vagus–brain cholinergic circuit through which oral Bacteroides fragilis suppresses seizures in mouse models and improves outcomes in a pediatric refractory epilepsy trial. The study links colonic ChAT-positive cells, vagal transmission, and Lactobacillus enrichment, providing a mechanistic framework for microbiota-targeted epilepsy research.
-
Nonivamide: TRPV1 Assay Design Beyond Cancer
2026-08-19
Nonivamide is a capsaicin analog that connects TRPV1 pharmacology with cancer cell growth inhibition and neuroimmune assay design. This article explains how to distinguish direct apoptosis from circuit-level inflammation effects and how to build more interpretable workflows.
-
Puromycin Dihydrochloride: Assay Logic
2026-08-19
Puromycin dihydrochloride is more than a selection reagent: it is a mechanistic probe for translation, ribosome behavior, and experimental confounding. This article shows how to separate antibiotic selection from phenotype measurement, using telomere biology research as a model for better assay design.
-
Prochlorperazine: From Antiemesis to Assay Logic
2026-08-18
Prochlorperazine is a dopamine D2 receptor antagonist with applications spanning antiemetic therapy and experimental melanoma research. This article develops a temporal, mechanism-aware framework for translating its pharmacology into more interpretable cell-based assays.
-
ARCA Cy3 EGFP mRNA (5-moUTP): Cell Assays
2026-08-18
This scenario-driven guide shows how ARCA Cy3 EGFP mRNA (5-moUTP), SKU R1008, can separate mRNA uptake, intracellular trafficking, translation, and assay-related cytotoxicity in mammalian cell workflows. It combines practical handling parameters with evidence-based interpretation and vendor-selection criteria.
-
Palmitic acid: Practical Protocol and QC Guide
2026-08-17
Palmitic acid (SKU N2456), also known as hexadecanoic acid, provides a characterized saturated long-chain fatty acid for controlled studies of lipid metabolism, protein palmitoylation, metabolic disorder research, and inflammation signaling studies. It is intended for solvent-based preparation rather than direct aqueous dissolution or long-term solution storage, so matched vehicle controls and prompt use are essential.